ROTHBLATT MARTINE A sold UTHR
September 29, 2025 · Form 4 insider transaction
ROTHBLATT MARTINE A sold 415 shares of United Therapeutics Corporation at $418.12 per share, a transaction worth $173.5K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
415
Price
$418.12
Total value
$173.5K
InsiderROTHBLATT MARTINE A
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 29, 2025
Filing dateOctober 1, 2025
Shares owned after3,514
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on May 2, 2025. This plan will continue until the earlier of: (a) exhaustion of a tranche of 294,000 stock options that expire March 15, 2026; or (b) December 31, 2025.